Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Vantage Australia Explores HealthTech's Future in the Latest Episode of The Vantage View 2024-07-26 17:05
Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-07-26 10:16
Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development 2024-07-26 09:33
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy 2024-07-25 20:00
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE) 2024-07-25 17:46
Australasian College of Pharmacy and MedAdvisor Solutions Launch MedAdvisor software training for the Queensland Community Pharmacy Scope of Practice Pilot 2024-07-25 05:00
Telix Successfully Prices A$650 Million Convertible Bonds 2024-07-24 07:51
Telix Announces A$600 Million Convertible Bonds Offering 2024-07-23 16:35
Linical Named Best Global CRO by Global Health & Pharma Magazine 2024-07-23 09:00
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs 2024-07-23 08:00
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million 2024-07-23 01:23
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency 2024-07-22 19:48
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors 2024-07-22 08:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration 2024-07-19 22:01
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms 2024-07-19 12:30
Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results 2024-07-19 07:15
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development 2024-07-19 00:00
1 23 24 25 26 27 413